In the past week, FBRX stock has gone up by 30.69%, with a monthly gain of 56.74% and a quarterly surge of 86.27%. The volatility ratio for the week is 14.27%, and the volatility levels for the last 30 days are 14.58% for Forte Biosciences Inc The simple moving average for the last 20 days is 12.27% for FBRX stock, with a simple moving average of 31.21% for the last 200 days.
Is It Worth Investing in Forte Biosciences Inc (NASDAQ: FBRX) Right Now?
FBRX has 36-month beta value of 2.93. Analysts have mixed views on the stock, with 4 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for FBRX is 9.89M, and currently, short sellers hold a 1.68% ratio of that float. The average trading volume of FBRX on July 03, 2025 was 87.17K shares.
FBRX) stock’s latest price update
The stock of Forte Biosciences Inc (NASDAQ: FBRX) has increased by 11.25% when compared to last closing price of $12.44. Despite this, the company has experienced a 30.69% gain in its stock price over the last five trading sessions. businesswire.com reported 2025-06-25 that DALLAS–(BUSINESS WIRE)–Forte Biosciences, Inc. (Nasdaq: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced the pricing of a public offering of 5,630,450 shares of its common stock at a price to the public of $12.00 per share and, in lieu of common stock to certain investors who so chose, pre-funded warrants to purchase up to 619,606 shares of common stock at a price to the public of $11.999 per pre-funded warrant, which rep.
Analysts’ Opinion of FBRX
Ladenburg Thalmann, on the other hand, stated in their research note that they expect to see FBRX reach a price target of $2.75. The rating they have provided for FBRX stocks is “Buy” according to the report published on April 08th, 2024.
Chardan Capital Markets gave a rating of “Buy” to FBRX, setting the target price at $3.50 in the report published on September 20th of the previous year.
FBRX Trading at 46.66% from the 50-Day Moving Average
After a stumble in the market that brought FBRX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -51.74% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at FBRX starting from Riley Antony A, who purchase 22,514 shares at the price of $5.55 back on Nov 21 ’24. After this action, Riley Antony A now owns 30,776 shares of Forte Biosciences Inc, valued at $124,998 using the latest closing price.
Stock Fundamentals for FBRX
The total capital return value is set at -1.17. Equity return is now at value -130.27, with -110.01 for asset returns.
Currently, EBITDA for the company is -35.44 million with net debt to EBITDA at 1.02. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.22.
Conclusion
To put it simply, Forte Biosciences Inc (FBRX) has had a better performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
